BLUE HELIX HEALTH AS

Operating

Forskning og utvikling innen nevrovitenskap. It tjenester og programmer som benytter Big Data, AI(Artificial Intelligence)og nevrovitenskap for å vise nye muligheter og skjulte trender innen store datamengder. Konsulenttjenester generelt og spesielt innen området IT, programmeringsutvikling, skytjenester og nevrovitenskap. Investeringer i aksjer, eiendom og andre finansielle instrumenter.

Forskning og utvikling, programvareutvikling, konsulenttjenester og investeringer.

Organization

CEO: FM
Frode Marc Bohan1968
Chairman of the board: FM
Frode Marc Bohan1968
Years since formation: 9 years; since Aug 23, 2017
Type: Limited company
VAT registered: Yes
Number of employees: 0

Ownership

Number of shares and share classes: 9,350; 1 share class
Total number of shareholders: 6; 5 companies, 1 person
Belongs to group of

Financials

Annual total result 2025: -9,279,247; NOK
Total equity 2025: -28,700,141; NOK

Last update: Jul 11, 2026

Management

Management / administration

Name	Role	Shares
FM Frode Marc Bohan 1968	Managing Director/CEO	-

Board

Name	Role	Shares
FM Frode Marc Bohan 1968	Chairman	-

Others

Name	Role	Shares
M MOORE AS	Auditor	-

Top 10 individual shareholders

Name	Role	Shares
FM Frode Marc Bohan 1968	-	89.09 % directly 2.67 % indirectly 86.42 %
KØ Kim Øien 1968	-	3.21 % indirectly
MZ Mathias Ziegler 1961	-	2.31 % indirectly
HO Hege Olstad 1973	-	1.63 % indirectly
KR Kjetil Ramsøy 1971	-	1.63 % indirectly

Last update: Oct 21, 2024

Ownership

Company shareholders

Name	Share class	Total number of shares	Share
B BOHAN & CO AS	Ordinary shares	8,080	86.42 %
C CINCO INVEST AS	Ordinary shares	304	3.25 %
N NICOLINE INVEST AS	Ordinary shares	300	3.21 %
FM Frode Marc Bohan 1968	Ordinary shares	250	2.67 %
S STOEHRSSON AS	Ordinary shares	216	2.31 %
T THEO INVESTMENTS AS	Ordinary shares	200	2.14 %

Last update: Jun 2, 2025

Group structure

BOHAN & CO AS
Total operating income 2023: NOK 6,874,227
Operating profit 2023: NOK 1,455,587
Employees: 0

Financials

in NOK

Summary

Year	2025	2023	2022	2021
Total operating income	0	118,500	0	0
Annual Total Result	-9,279,247	-3,709,623	-1,509,602	-21,261
Total assets	2,648,503	657,834	1,526,003	3,012,952
Total liabilities	31,348,644	2,885,358	43,903	21,250
Total equity	-28,700,141	-2,227,524	1,482,100	2,991,702

P&L

Year	2025	2023	2022	2021
Total operating income	0	118,500	0	0
Total operating costs	6,819,882	3,831,274	1,513,807	21,261
Operating result	-6,819,882	-3,712,774	-1,513,807	-21,261
Financial income/costs	-2,459,366	3,151	4,205	0
Profit before tax	-9,279,247	-3,709,623	-1,509,602	-21,261
Total tax & extraordinary income/cost	0	0	0	0
Annual Total Result	-9,279,247	-3,709,623	-1,509,602	-21,261

Balance overview

Year	2025	2023	2022	2021
Total fixed assets	480,666	251,278	1,413,778	1,312,500
Total current assets	2,167,837	406,557	112,225	1,700,452
Total assets	2,648,503	657,834	1,526,003	3,012,952
Short term debt	781,057	442,345	22,653	0
Long term debt	30,567,587	2,443,013	21,250	21,250
Total liabilities	31,348,644	2,885,358	43,903	21,250
Contributed capital	3,370,000	3,030,000	3,030,000	3,030,000
Retained earnings	-32,070,141	-5,257,524	-1,547,900	-38,298
Total equity	-28,700,141	-2,227,524	1,482,100	2,991,702
Total equity and liabilities	2,648,503	657,834	1,526,003	3,012,952

Classification

21st company classification

BETA

Small company

Type of organization

Limited company

Classification of institutional sector

INNL

Domestic sectors

A_IKKE-FIN

Non-financial corporations

2100

Private non-financial incorporated enterprises

BLUE HELIX HEALTH AS919 451 165